| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdd8cd8eb5adfc56cbfbbbb0936e3943
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75f4c74972c2477c3edef0f73216c1a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f3db0d8c13bafdeb7c671ce61660e36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59f6260a93fe7f0aee93d2cbbf27b93d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a129cde39c83aa3792d57f690f82bf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a3ace35986e8e8a76ae0f2e7e21269c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4c61d7a061ab76276f25d0e2c81eed9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate |
2009-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d1127a4a0dd224519398fa45740f06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f58fdc0e6b3c77cd013452310d86f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53681112b3e7950a6830a5f7b8bf9701
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_487b0e30991ff520025311d49e2f2809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e453a0c446035153dee246040c24e20b |
| publicationDate |
2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010028089-A2 |
| titleOfInvention |
Agents and methods for treatment of pain |
| abstract |
The invention provides agents useful for treating pain. An exemplary agent comprises or consists of the a portion of a retroviral Tat protein. One such agent is the peptide Tat-NR2B9c. This peptide has previously been described as an agent for inhibiting damaging effects of stroke and similar conditions via inhibition of PSD95 interactions with NMDA receptors and/or NOS. The present application provides data showing that the Tat- NR2B9c peptides is effective in alleviation of pain. The alleviation of pain can be obtained at a dose of the peptide below the dose required to inhibit PSD-95 interactions with NMDAR or NOS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10107796-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11083776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10995125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015164378-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013543378-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10613079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108079279-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10048275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10414808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541098-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019134150-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3693001-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015518836-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9594075-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3524257-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019107017-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10975129-B2 |
| priorityDate |
2008-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |